Julie Larkin, MD
Infectious Disease · Sarasota, FLNPI 1336246875
Payments from drug & device makers
What this record shows
3 manufacturers reported payments, led by Astellas Pharma US Inc at 51.1% of the total. Reporting peaked in 2022 at $137 and has fallen 52.8% since, to $65 in 2025. That places this record below the midpoint for infectious disease clinicians in FL, where the typical reported total is $652.
Across 9 payments — averaging $37.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$172
- Insmed, Inc.$118
- Aimmune Therapeutics, Inc.$46
What the payments were for
- Food & beverage$16449%
- Education$17251%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 3 | $172 |
| Insmed, Inc. | 4 | $118 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
How this compares
$336 in reported general payments places this provider in the 40th percentile of 669 infectious disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 32 | $27,157 |
| ErtapenemErtapenem Sodium | 11 | $7,496 |
| Cefepime Hcl | 38 | $6,236 |
| Meropenem | 13 | $3,645 |
| Vancomycin Hcl | 25 | $2,836 |
| CeftriaxoneCeftriaxone Sodium | 34 | $2,529 |
| Cephalexin | 98 | $1,957 |
| CefuroximeCefuroxime Axetil | 31 | $954 |
| Doxycycline Hyclate | 37 | $784 |
| Cefazolin Sodium | 14 | $711 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $467 |
| Amoxicillin | 23 | $461 |
| Fluconazole | 21 | $424 |
| Ciprofloxacin Hcl | 19 | $361 |
| Ethambutol Hcl | 14 | $319 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Sarasota
- Lennox ArchibaldGainesville$2.1M
- Moti RamgopalFort Pierce$1.1M
- Juan DiazAltamonte Springs$980K
- Charlotte-Paige RolleOrlando$619K
- Kenneth AlexanderOrlando$474K
- Douglas BrustMiami$359K
- Christopher CooperAltamonte Springs$278K
- Federico HinestrosaOrlando$276K
- Cynthia RiveraMiami Beach$265K
- Sally AlrabaaTampa$250K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.